Keyword search

View results
Sort Help
entries

Results

All (57)

All (57) (0 to 10 of 57 results)

  • 1. Biotechnology use and development survey, indicators for innovative biotechnology firms by firm size Archived
    Table: 27-10-0266-01
    Frequency: Every 2 years
    Description: Biotechnology use and development survey, indicators for innovative biotechnology firms by firms size for Canada, biennial survey from 1999 to 2005.
    Release date: 2008-09-26
  • 2. Biotechnology use and development survey, indicators for innovative biotechnology firms by sector Archived
    Table: 27-10-0267-01
    Frequency: Every 2 years
    Description: Biotechnology use and development survey, indicators for innovative biotechnology firms by sector, for Canada, biennial survey from 1999 to 2005.
    Release date: 2008-09-26
  • 3. Biotechnology use and development survey, indicators for innovative biotechnology firms by region Archived
    Table: 27-10-0268-01
    Frequency: Every 2 years
    Description: Biotechnology use and development survey, indicators for innovative biotechnology firms for Canada and by region , biennial survey from 1999 to 2005.
    Release date: 2008-09-26
  • 4. Innovators, Non-innovators and Venture Firms: What Is the Nature of Firms in Research and Development Services Industries? Archived
    Articles and reports: 88F0006X2007007
    Description: Results from the Survey of Innovation 2003 raised some interesting questions. First, an unexpected one-third of establishments in R&D services were not innovative. According to the guidelines of the Oslo Manual, innovative establishments are those that introduced a new or significantly improved product or process on to the market or into production, within a specified interval. Second, many of these non-innovative establishments indicated that satisfying existing customers was irrelevant to their firms success. This was very different response from all other types of firms.

    This working paper provides a potential explanation of these unexpected results, as well as an overview of available information on establishments in R&D services (NAICS 5417) in the context of professional services generally. The paper assembles descriptive data to show that non-innovative establishments in R&D services differ significantly from other non-innovative establishments and, while not innovative, they are nevertheless highly inventive. It presents some evidence to suggest that they are venture firms (firms relying on infusions of investment capital rather than revenues from sales to sustain their operations) and proposes a specific set of indicators that would facilitate resolution of the nature of firms in this industry group.

    Release date: 2007-12-20
  • 5. Selected Results of the Biotechnology Use and Development Survey 2005 Archived
    Articles and reports: 88F0006X2007006
    Description: This descriptive working paper provides highlights from the Biotechnology Use and Development Survey 2005. Data on innovative biotechnology firms are presented by region, sectors and firm size. The data include firm revenues, R&D activities, human resources, firm financing, age of firms, country of control and the proportion of publicly traded firms.
    Release date: 2007-12-05
  • 6. Results of the pilot survey on nanotechnologies Archived
    Articles and reports: 88-003-X200700210323
    Geography: Canada
    Description:

    Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.

    Release date: 2007-10-09
  • 7. International activities on the development of nanotechnology statistics Archived
    Articles and reports: 88-003-X200700210324
    Geography: Canada
    Description:

    Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.

    Release date: 2007-10-09
  • 8. Firm characteristics and fund-raising activities of biotech firms in Canada Archived
    Articles and reports: 88-003-X200700210325
    Geography: Canada
    Description:

    Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.

    Release date: 2007-10-09
  • 9. Start-up funding sources and biotechnology firm growth Archived
    Articles and reports: 88-003-X200700210326
    Geography: Canada
    Description:

    Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.

    Release date: 2007-10-09
  • 10. Overview and Discussion of the Results of the Pilot Survey on Nanotechnology in Canada Archived
    Articles and reports: 88F0006X2007005
    Description: This working paper provides results from a pilot survey on nanotechnology, which was appended to the Biotechnology Use and Development Survey 2005. The paper presents the conceptual issues and survey challenges relating to measurement of nanotechnology-related activities, as well as preliminary data on nanotechnology firms in Canada.
    Release date: 2007-08-31
Data (3)

Data (3) ((3 results))

Analysis (54)

Analysis (54) (20 to 30 of 54 results)

  • 21. Trends in Canadian Biotechnology Activity: 1997 to 2001 Archived
    Articles and reports: 88F0006X2004017
    Description:

    Using data from the 1997 Biotechnology Firm Survey and the 1999 and 2001 cycles of the Biotechnology Use and Development Survey, this article portrays the evolution of key indicators of Canadian biotechnology companies from 1997 to 2001.

    Release date: 2004-10-22
  • 22. Changes in the number of biotechnology innovative firms and revenues Archived
    Articles and reports: 88-003-X20040026930
    Geography: Canada
    Description:

    Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.

    Release date: 2004-06-30
  • 23. An Historical Comparison of Technological Change, 1998-2000 and 2000-2002, in the Private and Public Sectors Archived
    Articles and reports: 88F0006X2004007
    Description:

    This paper presents data on technological change that have been made comparable from the Survey of Electronic Commerce and Technology (SECT) for 2000 and 2002. It shows that when comparable data for the 1998 to 2000 and 2000 to 2002 periods (based on the definition and survey universe employed by SECT 2000) are used, the propensity to adopt new technologies in the private sector has remained constant at about 40%. The rate of technology adoption in the public sector remained at four out of five organizations introducing significantly improved technologies (a level about twice as high as that for the private sector). This rate also shows little change from 2000. The paper presents the comparable technological change data, while explaining differences in the wording of the survey questions and universe between the two reference years. Information is provided for private and public sectors, selected employment size groups and sectors of both private and public sectors.

    Release date: 2004-03-09
  • 24. Biotechnology Use and Development Survey: Methodology, Issues and Responses Archived
    Articles and reports: 88F0006X2004006
    Description:

    Biotechnology is a pervasive technology used in several industrial sectors, making collecting sound data a real challenge. This paper describes the methodology of the Biotechnology Use and Development Survey. Some of the specific issues dealt with are the definitions of biotechnology and innovative biotechnology firms, the target population, sampling, data collection procedures, and data quality evaluation.

    Release date: 2004-03-05
  • 25. Bioproduct development: an intrinsic part of Canadian biotechnology firms Archived
    Articles and reports: 88-003-X20040016791
    Geography: Canada, Province or territory
    Description:

    Data from the 2001 Biotechnology Use and Development Survey reveal that there are 133 biotechnology Canadian-based firms manufacturing or developing bioproducts. These mostly private 'home-grown' firms, located in Quebec, British Columbia and Ontario, are operating across all economic sectors. The largest share of their combined portfolio of 805 bioproducts is at the commercialization stage. Bioprocessing-based bioproducts (products developed or made using enzymes and bacteria culture) lead the way.

    Release date: 2004-03-05
  • 26. Why are Canadian biotech firms having problems raising financing capital? Archived
    Articles and reports: 88-003-X20030026570
    Geography: Canada
    Description:

    In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?

    Release date: 2003-06-27
  • 27. Strategic alliances in biotechnology: Characteristics and impact on performance indicators Archived
    Articles and reports: 88-003-X20030026571
    Geography: Canada
    Description:

    This article presents the results of a study that looks at the characteristics of Canadian biotechnology firms that form strategic alliances and measures the impact that such alliances have on their performance indicators.

    Release date: 2003-06-27
  • 28. Biotechnology research and development (R&D) in Canadian industry, 2000 Archived
    Articles and reports: 88-001-X20030047882
    Description:

    Biotechnology is an enabling technology - one that has been compared to electricity or microelectronics - because it has the potential to transform production processes, products and services in a wide range of sectors of the economy. At present, major applications of biotechnology are taking place in health, agrifood, and natural resources (e.g. forestry and mining). This survey is intended to quantify the level of industrial activity in biotechnology Research and Development by sector of application and to reveal trends in spending.

    Release date: 2003-06-05
  • 29. Features of Canadian Biotech Innovative Firms: Results from the Biotechnology Use and Development Survey - 2001 Archived
    Articles and reports: 88F0006X2003005
    Description:

    The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2001 Biotechnology Use and Development Survey. Within the last few years, except for the amount of financing capital raised, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 358 in 1999 to 375 in 2001. The Human Health sector outpaces all the other sectors in terms of the number of firms, human resources, biotechnology revenues, biotechnology research and development expenditures, amount of financing capital raised, and the number of products in the pipeline. Contrary to medium-sized and large firms where the personnel is more homogenous, small firms employ mostly highly-qualified workers. The 2001 data show a maturing trend in small firms. Most firms could not hire enough people to fill all their vacancies (estimated at 953 positions in Canada) for the 2001 year.

    Release date: 2003-03-28
  • 30. How Is the Canadian Biotechnology Evolving: A Comparison of the 1997 and 1999 Biotechnology Use and Development Surveys Archived
    Articles and reports: 88F0006X2003003
    Description:

    Results show that biotechnology companies in Canada are experiencing rapid growth and that Statistics Canada is now capturing more biotechnology activity. For example, between 1997 and 1999, Canadian biotechnology firms grew in number with core biotechnology firms increasing from 282 firms to 358. They brought in $1.9 billion in biotechnology revenues in 1999, compared with $813 million in 1997; they spent around $827 million on biotechnology research and development in 1999, compared with $494 million in 1997.

    Release date: 2003-03-10
Reference (0)

Reference (0) (0 results)

No content available at this time.

Sort Help

How are the results ordered?

The Sort by feature provides four options:

  • By date – sorts results by product release date starting with the most recent.
  • By most popular – gives priority to results that are most frequently selected by users, followed by the most recent.
  • By relevance is only needed or beneficial when you use the search box and submit a search query. Results are ordered by a combination of where the search term appears in the content, e.g., if it appears in the title, it likely means the product is more relevant to your search; how up to date or new the content in the product is; how popular the product is; and other factors.
  • By title – sorts results alphabetically.

Sort Help

How are the results ordered?

The Sort by feature provides three options:

  • By date – sorts results by product release date starting with the most recent.
  • By relevance is only needed or beneficial when you use the search box and submit a search query. Results are ordered by a combination of where the search term appears in the content, e.g., if it appears in the title, it likely means the product is more relevant to your search; how up to date or new the content in the product is; how popular the product is; and other factors.
  • By title – sorts results alphabetically.

Search Help

How do I use the filters and the search box?

  • You can initiate a search by entering keywords or selecting filters (e.g., under Subject, Geography, etc.) on the left side of the page.

  • Filters can be used together or in any combination. Each time you select a filter, the results on the page are updated.

  • To start a new search, click on the Clear all button above the search box or deselect each filter.

  • Specified keywords and filters appear above the search box. You can deselect any or all the tags to refine or clear your search.

How do I refine my search?

  • You can enter keywords in the search box. It is not necessary to use “+” or “, “ or “AND”.

  • You can delete some or all of the keywords from your search string.

  • Quotes around keywords limit the search to a specific phrase.

    • For example, “labour force survey” will limit results to products containing this phrase.

  • Use “or” between keywords to obtain results that contain one or more search terms.

    • For example, labour or­ force or survey will limit results to products containing any or all of these words.

How does the search work?

  • This search looks for results that have your query term in the title, description, subject, geography, product number or other information about the product.

    • For example, when searching the term ‘Diseases’, all results with the word ‘Diseases’ in the title, description or tagged the subject appear.

  • The text within an article or publication are not searched. For full text searching of articles, use the site search.

Date modified: